Emyria Ltd (ASX:EMD)'s Michael Winlo speaks to Proactive soon after the news of a successful share placement to strategic investor Tattarang – one of Australia’s largest private investment groups owned by the Forrest family. Tattarang will invest $5 million in the data-backed drug development and care delivery company and will receive a total of 20 million shares at A$0.25 per share resulting in a 7.3% interest in Emyria.
Emyria delighted with $5 million strategic investment from Tattarang
